Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Research and Markets: Available Now: Thought Leader Insight & Analysis: Psoriasis
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c93073) has announced the addition of "Thought Leader Insight & Analysis: Psoriasis" to their offering. Psoriasis Thought Leader Panel #13 continues the researcher's discussion with US and European Thought Leaders. During these conversations the Panelists offered their insight into the following: -...
- Research articles 2008-05-28
- Research and Markets: Serono IMS Company Profile
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c60151) has announced the addition of Serono IMS Company Profile to their offering.
- Research articles 2007-06-19
- Stocks to Watch - SOEN, DYAX, AMLN, JOSB.
- M2 PRESSWIRE-7 September 2006-SmallCapReview: Stocks to Watch - SOEN, DYAX, AMLN, JOSBC1994-2006 M2 COMMUNICATIONS LTD RDATE:07092006 SmallCapReview Stocks to Watch for today include - Solar EnerTech (OTCBB: SOEN), Dyax (Nasdaq: DYAX), Amylin Pharmaceuticals (Nasdaq: AMLN), JoS. A. Bank Clothiers (Nasdaq: JOSB)...
- Research articles 2006-09-07
- MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
- To: NATIONAL EDITORSTo: NATIONAL EDITORS
- Research articles 2007-12-13
- BioSeek to Collaborate With Merck Serono to Assess Potential Drug Candidates
- BURLINGAME, Calif. -- BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that it has entered into a collaboration agreement with Merck KGaA, Darmstadt, Germany acting for its division Merck Serono. Under the collaboration, BioSeek will apply its BioMAP([R]) Systems to evaluate Merck...
- Research articles 2008-05-20
- Swiss life sciences company Novartis has decided not to proceed with an offer for Berna Biotech
- Swiss life sciences company Novartis Basel has decided not to proceed with an offer for Berna Biotech (Bern, Switzerland). Novartis had announced that it was considering the acquisition in November following an offer to Berna from Dutch biotechnology company Crucell Leiden. Crucell is now offering $450m (372m [euro]) for Berna,...
- Research articles 2006-01-23
- Research and Markets: 2007 Profile Provides an in-Depth Insight into the Dealmaking Activity and Interests of Merck Serono
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c70290) has announced the addition of Merck Serono Dealmaking Profile 2007 to their offering.
- Research articles 2007-10-03
- Drugmaker to pay $704M fine in health care fraud
- WASHINGTON -- Serono Labs agreed Monday to pay $704 million in fines to the federal government and plead guilty to fraud charges for illegally inducing doctors to prescribe its AIDS drug, Serostim. The fine is the third-largest health care fraud settlement for the Justice Department and will be used...
- Research articles 2005-10-18
- DOJ: Serono to Pay $704 Million for Illegal Marketing of AIDS Drug
- WASHINGTON, Oct. 17 /U.S. Newswire/ -- Swiss corporation, Serono, S.A., together with its U.S. subsidiaries and related entities, has agreed to pay $704 million to resolve criminal charges and civil allegations in connection with illegal schemes to promote, market and sell its drug, Serostim, the Justice Department announced today. ...
- Research articles 2005-10-17
- Full Year 2005 Serono S.A. Earnings Conference Call - Research and Markets offers a brief of 'Serono S.A.' Conference Call
- DUBLIN, Ireland -- The Serono S.A. (NYSE:SRA) Corporate Conference Call took place on 6-Feb-06 3:00pm CET.
- Research articles 2006-02-06
- Naked Short Web Site announces CRYO, SRA, HEM, INTN, IOX, SPAB have been removed from threshold lists today.
- M2 PRESSWIRE-5 August 2005-BUYINS.NET: Naked Short Web Site announces CRYO, SRA, HEM, INTN, IOX, SPAB have been removed from threshold lists todayC1994-2005 M2 COMMUNICATIONS LTD RDATE:05082005 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX...
- Research articles 2005-08-05
- PAL, PLAY, SPAB, SRA, CDNR, ORTN have also been added to naked short lists today.
- M2 PRESSWIRE-21 July 2005-BUYINS.NET: PAL, PLAY, SPAB, SRA, CDNR, ORTN have also been added to naked short lists todayC1994-2005 M2 COMMUNICATIONS LTD RDATE:21072005 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked...
- Research articles 2005-07-21
- Balanced Scorecard Collaborative Honors Endesa, Puertos del Estado, and Serono with Prestigious Hall of Fame Award.
- MADRID, Spain and LINCOLN, Massachusetts, June 9 /PRNewswire/ -- - Breakthrough Performance Results Lauded at European Summit Balanced Scorecard Collaborative, Inc. today announced it has named Endesa, Puertos del Estado, and Serono to the Balanced Scorecard Hall of Fame for Executing StrategyTM...
- Research articles 2005-06-09
- Serono's Manufacturing Facility of Corsier-Sur-Vevey Receives ISO 14001:2004 Certification.
- GENEVA, Switzerland, May 30 /PRNewswire/ -- Serono (virt-x: SEO and NYSE: SRA), the third largest biotechnology company in the world, announced today that the Serono Biotech Center, its manufacturing facility of Corsier-sur-Vevey in Switzerland, has received ISO 14001:2004 certification, the...
- Research articles 2005-05-30
- World Markets: Europe
- Upbeat results from Ericsson and firmer energy stocks helped bourses end the week on a bright note. But disappointing quarterly sales skimmed 4.7 per cent from L'Oreal, while Serono shed 5.4 per cent as an unexpected charge forced the Swiss biotech company to post a deep first-quarter net loss. UBS,...
- Research articles 2005-04-23
- Serono posts surprise first-quarter net loss
- GENEVA AFP — Swiss biotechnology company Serono announced a surprise net loss of 567.7 million dollars (439.6 million euros) in the first quarter of 2005 after it set aside 725 million dollars to cover a legal probe in the United States. Serono said in a statement that it had...
- Research articles 2005-04-22
- Serono pleads guilty to marketing scam
- SERONO LABORATORIES formally pleaded guilty in December to criminal charges involving schemes to promote, market and sell its AIDS-wasting drug Serostim.The company has agreed to pay a $136.9 million criminal fine and $567 million to settle civil liabilities.
- Research articles 2006-02-01
- ZymoGenetics Presents Results of Healthy Volunteer Study with TACI-Ig at 4th International Congress on Autoimmunity
- SEATTLE -- ZymoGenetics, Inc. (Nasdaq:ZGEN) today announced the results of a healthy volunteer study with TACI-Ig, a potential therapy for autoimmune diseases and B-cell malignancies, which were presented at the 4th International Congress on Autoimmunity in Budapest, Hungary, on Saturday, November 6. The study results indicated that TACI-Ig was safe...
- Research articles 2004-11-08
- SMI gainers & losers: May
- GAINERS: 30.4.04 28.5.04 SGS 680.00 722.00 6.18% Clariant 16.45 ...
- Research articles 2004-07-01
- EMD Serono Canada Inc.-Raptiva(R): First Biologic Treatment for Psoriasis to Receive Public Reimbursement in Two Atlantic Provinces.
- TORONTO, ONTARIO, Feb 5, 2008 Marketwire via COMTEX -- EMD Serono Canada Inc. announces that RaptivaR efalizumab is the first biologic treatment for psoriasis to be approved for coverage through the provincial formularies in both Nova Scotia an TORONTO, ONTARIO, Feb 5, 2008 Marketwire via COMTEX...
- Research articles 2008-02-05
- << Previous
- page 1 of 6
- Next >>
Content Types
Refining Tags
- Merck & Co. Inc. (21 results)
- Clariant Corp. (8 results)
- biotechnology (7 results)
- Swisscom AG (7 results)
- agreement (6 results)
- Novartis AG (6 results)
- ABB (6 results)
- Sales (6 results)
- Holcim Ltd. (5 results)
- Nestle S.A. (5 results)
- patient (5 results)
- Roche Holding AG (5 results)
- Amgen Inc. (4 results)
- FDA (4 results)
- UBS AG (4 results)
- Adecco (4 results)
- HEALTHCARE (3 results)
- life science (3 results)
- marketing (3 results)
- clinical trial (3 results)
- Celera Genomics (3 results)
- Nasdaq Stock Market Inc. (3 results)
